Gilead Sciences (GILD) Change in Taxes (2009 - 2026)

Gilead Sciences (GILD) reported Change in Taxes of -$29.0 million for Q1 2026, up 94.75% on a YoY basis from -$14.9 million in Q1 2025, and up 78.36% quarter-over-quarter from -$134.0 million in Q4 2025.

Gilead Sciences (GILD) Change in Taxes (2009 - 2026) Analysis & Trends

Gilead Sciences has reported Change in Taxes for 18 years, with the latest figure at -$29.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Taxes rose 94.75% year-over-year to -$29.0 million; the trailing twelve-month figure through Mar 2026 stood at -$1.6 billion (down 47.3% YoY), and the FY2025 full-year result was -$2.1 billion, down 187.98% from the prior year.
  • Change in Taxes for Q1 2026 stood at -$29.0 million, up from -$134.0 million in the prior quarter.
  • The five-year high for Change in Taxes was $536.0 million in Q4 2024, with the low at -$1.3 billion in Q2 2025.
  • Historically, Change in Taxes has averaged -$294.2 million across 5 years, with a median of -$134.0 million in 2025.
  • The largest YoY upside for Change in Taxes was 176.79% in 2024 against a maximum downside of 4082.14% in 2024.
  • Gilead Sciences' Change in Taxes stood at $119.0 million in 2022, then slumped by 686.55% to -$698.0 million in 2023, then soared by 176.79% to $536.0 million in 2024, then tumbled by 125.0% to -$134.0 million in 2025, then jumped by 78.36% to -$29.0 million in 2026.
  • The last three Change in Taxes figures came in at -$29.0 million (Q1 2026), -$134.0 million (Q4 2025), and -$122.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 411.19 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn -
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -81.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 71.00 Mn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -29.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 187.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -683.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.00 Mn
Mar 31, 2026 -29.00 Mn
Dec 31, 2025 -134.00 Mn
Dec 31, 2025 -134.00 Mn
Sep 30, 2025 -122.00 Mn
Sep 30, 2025 -122.00 Mn
Jun 30, 2025 -1.30 Bn
Jun 30, 2025 -1.30 Bn
Mar 31, 2025 -552.00 Mn
Mar 31, 2025 -552.00 Mn
Dec 31, 2024 536.00 Mn
Dec 31, 2024 536.00 Mn
Sep 30, 2024 111.00 Mn
Sep 30, 2024 111.00 Mn
Jun 30, 2024 -1.17 Bn
Jun 30, 2024 -1.17 Bn
Mar 31, 2024 -208.00 Mn
Mar 31, 2024 -208.00 Mn
Dec 31, 2023 -698.00 Mn
Dec 31, 2023 -698.00 Mn